Complement Inhibitors Market Size, Share & Industry Analysis, By Drug (Eculizumab, Ravulizumab, Pegcetacoplan, Iptacopan, Sutimlimab, Avacincaptad pegol, & Others), By Disease Indication (PNH, Atypical Hemolytic Uremic Syndrome, Generalized Myasthenia Gravis, Geographic Atrophy, Cold Agglutinin Disease), By Age Group, By Type (Branded, Biosimilar, & Others), By Target Pathway Inhibitors (C5, C3, C1s, Factor B, Factor D, & Others), By Route of Administration, By Distribution Channel (Hospital Pharmacies, Drug Stores, Retail/Online Pharmacies, & Others), & Regional Forecast, 2026-2034